Richard Aplenc
University of Pennsylvania
H-index: 57
North America-United States
Top articles of Richard Aplenc
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Racial and ethnic disparities in acuity of presentation among children with newly diagnosed acute leukemia | Pediatric Blood & Cancer | Lena E Winestone Kelly D Getz Yimei Li Evanette Burrows Michael E Scheurer | 2024/1 |
DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children's … | Clinical Cancer Research | Vivek M Shastri Lata Chauhan Mohammed Gbadamosi Todd A Alonzo Yi-Cheng Wang | 2024/2/9 |
Household income and health‐related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research | Cancer Medicine | Haley Newman Yimei Li Yuan‐Shung V Huang Caitlin W Elgarten Regina M Myers | 2024/4 |
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia | Cancer | Jenny Ruiz Yimei Li Lusha Cao Yuan‐Shung V Huang Vicky Tam | 2024/3/15 |
Prognostic Impact of Co-occurring Mutations in FLT3-ITD Pediatric Acute Myeloid Leukemia | Blood Advances | Katherine Tarlock Robert B Gerbing Rhonda E Ries Jenny L Smith Amanda Leonti | 2024/2/2 |
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia | Blood Advances | Oussama Abla Rhonda E Ries Tim Triche Jr Robert B Gerbing Betsy Hirsch | 2024/4/23 |
Applying machine learning to identify pediatric patients with newly diagnosed acute lymphoblastic leukemia using administrative data | Pediatric Blood & Cancer | Lusha Cao Yuan‐shung Huang Kelly D Getz Alix E Seif Jenny Ruiz | 2024/3 |
Success of Centralized Manufacturing of CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML | Transplantation and Cellular Therapy | Brian Bowser Xiaoyi Yang John Roach Julie Blake Kate Donnelly | 2024/2/1 |
Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study | Pediatric blood & cancer | Juliette Renaud Bianca F Goemans Franco Locatelli Martina Pigazzi Shelagh Redmond | 2024/4/14 |
Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship | Pediatric Blood & Cancer | Jenny Ruiz Rebecca K Kelly Richard Aplenc Theodore W Laetsch Alix E Seif | 2024/2/26 |
Bayesian semiparametric model for sequential treatment decisions with informative timing | Biostatistics | Arman Oganisian Kelly D Getz Todd A Alonzo Richard Aplenc Jason A Roy | 2024/1/16 |
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial | Cancers | Anneke D van Dijk Fieke W Hoff Yihua Qiu Stefan E Hubner Robin L Go | 2024/4/9 |
Reinfusion of CD19 CAR T Cells for Relapse Prevention and Treatment in Children with Acute Lymphoblastic Leukemia | Blood Advances | Regina M Myers Kaitlin J Devine Yimei Li Sophie Lawrence Allison Barz Leahy | 2024/2/22 |
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. | Clinical Cancer Research: an Official Journal of the American Association for Cancer Research | Vivek M Shastri Lata Chauhan Mohammed Gbadamosi Todd A Alonzo Yi-Cheng Wang | 2024/1/10 |
INSPIRED Symposium Part 5: Expanding the Use of CAR T cells in Children and Young Adults | Aimee C Talleur Vanessa A Fabrizio Richard Aplenc Stephan A Grupp Crystal Mackall | 2024/4/7 | |
Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy | Pediatric blood & cancer | John C Molina Yimei Li William R Otto Tamara P Miller Kelly D Getz | 2023/1 |
Impact of Molecular Risk on Efficacy of Blood and Marrow Transplantation for Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group | Blood | Benjamin J Huang Lauren K Meyer Adam Lamble Jim Wang Rhonda E Ries | 2023/11/2 |
ACS10-Cytarabine Pharmacogenomics Score Impacts Survival in Pediatric AML Patients Treated on AAML1031 Trial and Associates with Outcome Differences in Black AML Patients | Blood | Richard J Marrero Vivek M Shastri Richard Aplenc Todd Cooper Todd A Alonzo | 2023/11/28 |
Acute and chronic kidney injury during therapy for pediatric acute leukemia: A report from the Leukemia Electronic Abstraction of Records Network (LEARN) | Pediatric blood & cancer | Wendy Hsiao Yimei Li Kelly Getz Lusha Cao Edward Krause | 2023/12 |
Racial and Ethnic Disparities in Childhood and Young Adult Acute Lymphoblastic Leukaemia: A Children’s Oncology Group Cohort Study | The Lancet Haematology | Sumit Gupta Yunfeng Dai Zhiguo Chen Lena E Winestone David T Teachey | 2023/2/1 |
